A nationwide, multicenter retrospective study on the effectiveness and safety of eribulin in Korean breast cancer patients (REMARK).
Park MH, Lee SJ, Noh WC, Jeon CW, Lee SW, Son GS, Moon BI, Lee JS, Kang SS, Suh YJ, Gwak G, Kim TH, Yoo YB, Kim HA, Kim MY, Kim JY, Jeong J.
Park MH, et al. Among authors: jeon cw.
Breast. 2020 Dec;54:121-126. doi: 10.1016/j.breast.2020.09.004. Epub 2020 Sep 16.
Breast. 2020.
PMID: 32980648
Free PMC article.